Policy & Regulation Today - October 21, 2026

The latest in policy & regulation: 6 developments from the past day, tracked and curated by the HealthTech Cube news desk. The lead story: FDA Official Believes GenAI-enabled Tools Will Need to Be Assessed Like a Physician.

FDA Official Believes GenAI-enabled Tools Will Need to Be Assessed Like a Physician

MedCity News2026-10-20

FDA, MHRA officials eye streamlined frameworks for regulating genAI

RAPS2026-10-20

FDA solidifies stance on mobile apps, software used with prescription drugs in final guidance

Fierce Pharma2026-10-20

Meet The Attorneys Behind ACA Broker Registration Suit

Law3602026-10-20

GSK Immunotherapy Gets Accelerated FDA Approval for Treating Rectal Cancer

The GSK cancer immunotherapy Jemperli is now approved for treating advanced cases of rectal cancer harboring a particular genetic signature. It’s a label expansion for Jemperli, which was initially approved as a treatment for endometrial cancer. The post GSK Immunotherapy Gets Accelerated FDA Approval for Treating Rectal Cancer appeared first on MedCity News.

medcitynews.com2026-10-20

Dems demand tougher standards for Medicaid tech contractors

Modern Healthcare2026-10-20

Follow the full firehose on the HTC Wire, refreshed automatically every day.